As Stat1-positive and Stat1-negative RT2-cancers were similarly susceptible to lysis by cytotoxic CD8+ T cells (Supplementary Fig. 1a), we depleted CD8 T cells with mAb before transplanting the cancer cells. The gene discussed is CD8A; the disease is cancer.